Skip to content

Röntgenium

Active
Private limited companyfounded 2021active for 5 yearsKoestraat 175, 8800 Roeselare, Belgium20 active companies are registered at this addressKBO/BCE: BE 0767.424.705
Summary

Röntgenium has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €86,886 and a net result of €206,386. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 24% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Medical imaging and medical laboratories
NACE 86910
1 site
Size
≈ €420,000turnover 2025, estimated
Equity
€86,886
Profit
€206,386
Turnover estimated from the gross margin
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts filed 12 days late1 deed in the Belgian Official Gazette
Why 95lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.48, cash €136,109Size: total assets €323,198Figures for financial year 2025 (filed 16-08-2026)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 61% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 52+20
equity 26.9% of total assets
Liquidity 65+19
short-term debt 66.3% · cash 42.1%
Profitability 100=
return on assets 63.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,138 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: 0.1%▲ +0.1 percentage points vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €8,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.48, compared with 1.04 in 2024, below the usual 1.5; short-term debt: 66.3% and cash: 42.1% of total assets), and 73.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 24% on solvency, 44% on liquidity, 80% on profitability and 97% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.48, cash €136,109
NBB · annual accounts
lowers risk · Size: total assets €323,198
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 16-08-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 20620 sector peers (2025).
NBB · sector comparison
Position among 20620 sector peers
Solvency
better than 24%
← weakest strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
22232425
2022 to 2025 · latest year €86,886
raises risk · 2025 accounts filed 12 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-08-2026, 12 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 4 filings
Deviation from the deadline
2025
12 days late
2024
25 days late
2023
26 days late
2022
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 23 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 August (4 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2022 to 2025net €206,386 ▲59.6%
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

2025 annual accounts filed late (12 days) Filed on 12 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00400338.

Turnover
≈ €420,000
Estimated: probably between €360,000 and €530,000
Total assets
€323,198▲ 21.2%
2024 · €266,596
Net result
€206,386▲ 59.6%
2024 · €129,349
Working capital
€103,948▲ 949%
2024 · €9,910
Trend over the years

2022 to 2025, 4 financial years

The operating result has risen three years in a row; 2025 is 63% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€271,745 2025 Net result€206,386 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2022202320242025
Operating result€52,299-€140,442▲ 169%€166,951▲ 18.9%€271,745▲ 62.8%
Net result€41,950within the sector's middle half-€109,887above the sector's middle half▲ 162%€129,349above the sector's middle half▲ 17.7%€206,386above the sector's middle half▲ 59.6%
Equity€46,950below the sector's middle half-€22,837below the sector's middle half▼ 51.4%€18,186below the sector's middle half▼ 20.4%€86,886within the sector's middle half▲ 378%
Total assets€66,703below the sector's middle half-€203,384within the sector's middle half▲ 205%€266,596within the sector's middle half▲ 31.1%€323,198within the sector's middle half▲ 21.2%
Debt€19,753-€180,547▲ 814%€248,410▲ 37.6%€236,312▼ 4.9%
Working capital€38,223within the sector's middle half-€12,606below the sector's middle half▼ 67.0%€9,910below the sector's middle half▼ 21.4%€103,948within the sector's middle half▲ 949%
Solvency70.4%within the sector's middle half-11.2%below the sector's middle half▼ 59.2pp6.8%below the sector's middle half▼ 4.4pp26.9%below the sector's middle half▲ 20.1pp
Current ratio2.94within the sector's middle half-1.07below the sector's middle half▼ 1.871.04below the sector's middle half▼ 0.031.48within the sector's middle half▲ 0.44
Return on assets (ROA)62.9%above the sector's middle half-54.0%above the sector's middle half▼ 8.9pp48.5%above the sector's middle half▼ 5.5pp63.9%above the sector's middle half▲ 15.3pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €323,198
Fixed assets €4,841 ▼ 41.5%
Current assets €318,357 ▲ 23.2%
Equity and liabilities €323,198
Equity €86,886 ▲ 378%
Debt €236,312 ▼ 4.9%
Debt's share of the balance-sheet total falls from 93.2% to 73.1%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€275,180▲
2024 · €170,161
Cash flow
€209,821▲
2024 · €132,559
Debt to equity
2.72▼
2024 · 13.66
ROE
237.5%▼
2024 · 711.3%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€214,409▼
2024 · €248,410
Income taxes
€64,742▲
2024 · €37,053
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,713 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.

  • Micro
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.2% stopped otherwise
95.8% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,713 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet Code20242025
Assets
Total assets20/58€266,596€323,198▲
Fixed assets21/28€8,276€4,841▼
Tangible fixed assets22/27€8,276€4,841▼
Plant, machinery and equipment23€5,012€3,155▼
Furniture and vehicles24€3,263€1,686▼
Current assets29/58€258,320€318,357▲
Amounts receivable within one year40/41€50,212€51,731▲
Other amounts receivable41€50,212€51,731▲
Current investments50/53-€10,000
Cash at bank and in hand54/58€97,425€136,109▲
Deferred charges and accrued income490/1€110,684€120,518▲
Equity and liabilities
Total equity and liabilities10/49€266,596€323,198▲
Equity10/15€18,186€86,886▲
Contributions10/11€5,000€5,000=
Profit (loss) carried forward14€13,186€81,886▲
Amounts payable17/49€248,410€236,312▼
Amounts payable within one year42/48€248,410€214,409▼
Financial debts43-€9,514
Credit institutions430/8-€9,514
Trade debts44€4,312€0▼
Suppliers440/4€4,312€0▼
Taxes, remuneration and social security45€72,129€3,742▼
Taxes450/3€67,557€3,742▼
Remuneration and social security454/9€4,572€0▼
Other amounts payable47/48€171,968€201,153▲
Accrued charges and deferred income492/3-€21,903
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,209€3,435▲
Other operating charges640/8€3,807€4,652▲
Gross operating margin9900€173,968€279,832▲
Operating profit (loss)9901€166,951€271,745▲
Financial income75/76B€0-
Recurring financial income75€0-
Financial charges65/66B€549€617▲
Recurring financial charges65€549€617▲
Profit (loss) for the period before taxes9903€166,402€271,128▲
Income taxes67/77€37,053€64,742▲
Profit (loss) for the period9904€129,349€206,386▲
Profit (loss) for the period to be appropriated9905€129,349€206,386▲
Appropriation of the result
Profit (loss) to be appropriated9906€147,186€219,572▲
Profit (loss) brought forward from the previous period14P€17,837€13,186▼
Profit to be distributed694/7€134,000€137,686▲
Return on contributions (dividend)694€134,000€137,686▲

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€560€1,975€3,209€3,435▲ 7.0%
Other operating charges640/8€110€3,217€3,807€4,652▲ 22.2%
Gross operating margin9900€52,969€145,634€173,968€279,832▲ 60.9%
Operating profit (loss)9901€52,299€140,442€166,951€271,745▲ 62.8%
Financial income75/76B€29€140€0--
Recurring financial income75€29€140€0--
Financial charges65/66B€39€191€549€617▲ 12.2%
Recurring financial charges65€39€191€549€617▲ 12.2%
Profit (loss) for the period before taxes9903€52,289€140,392€166,402€271,128▲ 62.9%
Income taxes67/77€10,339€30,505€37,053€64,742▲ 74.7%
Profit (loss) for the period9904€41,950€109,887€129,349€206,386▲ 59.6%
Profit (loss) for the period to be appropriated9905€41,950€109,887€129,349€206,386▲ 59.6%
Line2022202320242025Change
Assets
Total assets20/58€66,703€203,384€266,596€323,198▲ 21.2%
Fixed assets21/28€8,727€10,231€8,276€4,841▼ 41.5%
Tangible fixed assets22/27€8,727€10,231€8,276€4,841▼ 41.5%
Plant, machinery and equipment23€8,727€6,870€5,012€3,155▼ 37.1%
Furniture and vehicles24-€3,361€3,263€1,686▼ 48.3%
Current assets29/58€57,976€193,153€258,320€318,357▲ 23.2%
Amounts receivable within one year40/41€10,165€38,358€50,212€51,731▲ 3.0%
Other amounts receivable41€10,165€38,358€50,212€51,731▲ 3.0%
Current investments50/53---€10,000-
Cash at bank and in hand54/58€5,718€40,383€97,425€136,109▲ 39.7%
Deferred charges and accrued income490/1€42,093€114,412€110,684€120,518▲ 8.9%
Equity and liabilities
Total equity and liabilities10/49€66,703€203,384€266,596€323,198▲ 21.2%
Equity10/15€46,950€22,837€18,186€86,886▲ 378%
Contributions10/11€5,000€5,000€5,000€5,000=
Profit (loss) carried forward14€41,950€17,837€13,186€81,886▲ 521%
Amounts payable17/49€19,753€180,547€248,410€236,312▼ 4.9%
Amounts payable within one year42/48€19,753€180,547€248,410€214,409▼ 13.7%
Financial debts43---€9,514-
Credit institutions430/8---€9,514-
Trade debts44€4,285€5,703€4,312€0▼ 100%
Suppliers440/4€4,285€5,703€4,312€0▼ 100%
Taxes, remuneration and social security45€14,089€60,944€72,129€3,742▼ 94.8%
Taxes450/3€14,089€60,944€67,557€3,742▼ 94.5%
Remuneration and social security454/9--€4,572€0▼ 100%
Other amounts payable47/48€1,379€113,900€171,968€201,153▲ 17.0%
Accrued charges and deferred income492/3---€21,903-
Line2022202320242025Change
Profit (loss) for the period9904€41,950€109,887€129,349€206,386▲ 59.6%
+ Depreciation and write-downs630€560€1,975€3,209€3,435▲ 7.0%
Operating cash flow (approximation)€42,510€111,862€132,559€209,821▲ 58.3%
Investment in fixed assets (approximation)--€3,479-€1,254€0-
Change in cash-€34,665€57,042€38,684▼ 32.2%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (4)
Financial year Type Filed Reference
31-12-2025 micro format 12-08-2026 2026-00400338
31-12-2024 micro format 25-08-2025 2025-00398092
31-12-2023 micro format 26-08-2024 2024-00379890
31-12-2022 micro format 28-08-2023 2023-00372122

Similar companies · same sector, comparable size

Of the 695 active companies whose main activity is medical imaging and medical laboratories (NACE 86910), figures are known for 528. 333 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 1 Gazette act processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 23 April 2021, Röntgenium was incorporated as a private limited company.1 Total assets went from €66,703 in 2022 to €323,198 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2022 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
12-08
NBB filing Annual accounts filed
financial year 2025 · micro format · 12 days late
2025
31-12
Financial Highest result from 2022 to 2025net €206,386 ▲59.6%
Operating result €271,745, net result €206,386, both a record.
25-08
NBB filing Annual accounts filed
financial year 2024 · micro format · 25 days late
2024
26-08
NBB filing Annual accounts filed
financial year 2023 · micro format · 26 days late
2023
28-08
NBB filing Annual accounts filed
financial year 2022 · micro format · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded23-04-2021
Financial year end31-12
Activities, NACEBEL 2025
86910Medical imaging and medical laboratories
86995Nutrition and dietetics services
E-invoicing
Not found in the Peppol Directory

No listing in the Peppol Directory under this enterprise or VAT number. That proves nothing: being listed there is voluntary.

What can you do?

Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.

If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if you send it electronically, you need their agreement on a secure channel. The invoice remains valid; it is the customer, not you, who risks a penalty. FPS Finance

If you follow this company, Checked tells you the day it appears in the Peppol register.

Register as of 28 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Roeselare · 1 establishment unit since 2021
registered office establishment The establishment unit on the map
Ground area
4.7 ha
Building footprint
1.1 ha
Building volume
763 m³
2 parcels, Flanders · tallest building 9.8 m. Linked by address, not a title deed.
20 companies at this address See who is registered here
1 establishment unit
Röntgenium
Rubensstraat 166, 2300 TurnhoutSpecialist medical practice
since 2021unit no. 2.317.241.611
2 parcels
Flanders 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
13453O0624/00Y000 Flanders 4.0 ha 1 · 8,932 m² -
36302B2115/00C000 Flanders 7,362 m² 1 · 2,567 m² 9.8 m
How the parcels are linked
Good to know
Both parcels match the address exactly.